3 Tips for Cutting Payer and Employer Gene Therapy Healthcare Expenses
CVS Health’s Health Trends Report 2021 highlighted three ways to cover high-cost gene therapies.
March 10, 2021 – CVS Health’s Health Trends Report 2021 highlighted three ways to cover high-cost gene therapies. These include:
• Using value-based contracting to reduce the risk for both payers and purchasers
• Identifying high-quality care facilities with the qualifications to oversee drug administration
• Embrace stop-loss insurance to bear the burden of expensive therapies like this
Click here to read the full report from CVS.
The VBP Blog is a comprehensive resource for all things related to value-based payments. Up-to-date news, informative webinars, and relevant blogs in the VBP sphere to help your organization find success.
Get even more VBP insights on LinkedIn & Twitter
More Trending Topics:
